Medication info

Discovisk Injection (Sodium Chondroitin Sulfate, Sodium Hyaluronate)

Prescription medicationInjectionsInjection
Ingredient · strength
Sodium Hyaluronate›16.5mg / 1mLSodium Chondroitin Sulfate›40mg / 1mL
Manufacturer / importer
Alcon Korea Ltd.
Appearance
A colorless and transparent solution in a glass pre-filled syringe sealed with rubber caps on both ends.
Packaging
1.0 milliliters/piece - 1.0 milliliters/piece
Approval status
Active

MFDS item code 200701053 · Approved 2007.01.25 · Insurance code 652400061

Summary

Main use
Adjunctive treatment for anterior segment ophthalmic surgery (including cataract extraction)
Who receives it
Adults
Adult administration
This product should be carefully injected aseptically into the anterior segment of the eye or into the anterior chamber before or after lens extraction. Instillation before lens extraction can protect the corneal endothelium by forming a coating that prevents damage from surgical instruments during cataract extraction. It can also be used to coat the tips of surgical instruments before intraocular lens implantation, as well as to coat the intraocular lens. Additional injection during anterior segment surgery can maintain the anterior chamber or replace fluid lost during surgery. At the end of surgery, thorough irrigation with sterile irrigating solution followed by aspiration is recommended to ensure complete removal from the eye.

Ingredients

Importer
Alcon Korea Ltd.

Efficacy & effects

Adjunctive treatment for anterior segment ophthalmic surgery (including cataract extraction)

View approved original text

This medication is used to assist in various anterior segment ophthalmic surgeries, including cataract extraction and artificial lens implantation. It helps maintain the stability of the eye during surgery and aids in recovery afterward. This contributes to the patient's vision recovery and improves surgical outcomes.

How it is given

Adult administration

This product should be carefully injected aseptically into the anterior segment of the eye or into the anterior chamber before or after lens extraction. Instillation before lens extraction can protect the corneal endothelium by forming a coating that prevents damage from surgical instruments during cataract extraction. It can also be used to coat the tips of surgical instruments before intraocular lens implantation, as well as to coat the intraocular lens. Additional injection during anterior segment surgery can maintain the anterior chamber or replace fluid lost during surgery. At the end of surgery, thorough irrigation with sterile irrigating solution followed by aspiration is recommended to ensure complete removal from the eye.

Precautions

This medication should not be used by patients who are allergic to its components. Due to the presence of sodium hyaluronate, there may be a temporary increase in intraocular pressure, so caution is warranted. As a viscoelastic agent used in surgical procedures, it may rarely cause side effects such as postoperative inflammation, infection, corneal edema, or corneal clouding. The phosphate component contained in this medication can very rarely cause corneal calcification in patients with severe corneal damage, so caution should be exercised. Failure to adhere to instructions or use equipment other than the provided cannula may result in separation of the cannula, leading to severe trauma. General precautions related to anterior segment surgery must be strictly followed. Although sodium hyaluronate and sodium chondroitin sulfate are highly purified biological substances, allergic reactions may still occur, so careful monitoring is necessary. The cannula should be used as a single-use only and should not be reused. It should only be used when the solution is clear, and should not be used if it is cloudy or altered. Care must be taken to avoid air bubbles forming in the injection solution, and the product should not be used if the container is damaged. This medication is intended exclusively for ophthalmic use, and the provided cannula and retaining ring are also for single-use only. It should be stored in a refrigerator and allowed to sit at room temperature for 20-40 minutes before use to reach an appropriate temperature. It should be kept in a safe place out of the reach of children, away from direct sunlight, and in a cool location. To maintain quality, do not transfer to another container, and take precautions to prevent misuse.

Side effects

Transient increase in intraocular pressure, postoperative inflammatory response, infection, corneal edema, corneal opacity, corneal calcification

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. Furthermore, it is important to store it at a refrigerator temperature between 2°C and 8°C to maintain effectiveness.

Appearance and packaging

Appearance

A colorless and transparent solution in a glass pre-filled syringe sealed with rubber caps on both ends.

Package unit

1.0 milliliters/piece - 1.0 milliliters/piece

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.